Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA;BCDAW · Entity 7752 | Director | April 14, 2022 | May 13, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date April 14, 2022 · Filed May 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.49 · Expires 2032-04-14 | Direct | 55,953 |
Reported balance
After 2022-04-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-04-14 · Grant · Acquired 31,085 · Balance 55,953 F1: The option vests and becomes exercisable as to one-third of the shares on December 22, 2021 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable as to one-third of the shares on December 22, 2021 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2022 Filed Sep 30, 2022 21:02 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,434 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001437749-22-023324 · rdgdoc.xml · derivative · entry 1 ZSEBO KRISZTINA M · CIK 0001590703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,868 Underlying: Common stock · 12,434 shares Expires 2032-06-10 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant. Read SEC document |
| April 14, 2022 Filed May 13, 2023 00:21 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 31,085 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001437749-23-014286 · rdgdoc.xml · derivative · entry 1 ZSEBO KRISZTINA M · CIK 0001590703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,953 Underlying: Common stock · 31,085 shares Expires 2032-04-14 F1 · derivative.exercise_date: The option vests and becomes exercisable as to one-third of the shares on December 22, 2021 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:49 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,434 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001437749-21-014883 · rdgdoc.xml · derivative · entry 1 ZSEBO KRISZTINA M · CIK 0001590703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,434 Underlying: Common stock · 12,434 shares Expires 2031-06-15 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant. Read SEC document |
| March 31, 2021 Filed Apr 8, 2021 00:24 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008508 · rdgdoc.xml · nonDerivative · entry 1 ZSEBO KRISZTINA M · CIK 0001590703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,980 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted March 31, 2021, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| December 31, 2020 Filed Jan 19, 2021 11:05 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000796 · rdgdoc.xml · nonDerivative · entry 1 ZSEBO KRISZTINA M · CIK 0001590703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted December 31, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.